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Abstract: Intestinal bacteria carry out many fundamental roles, such as the fermentation of 
non-digestible dietary carbohydrates to produce short chain fatty acids (SCFAs), which can 
affect host energy levels and gut hormone regulation. Understanding how to manage this 
ecosystem to improve human health is an important but challenging goal. Antibiotics are the 
front line of defence against pathogens, but in turn they have adverse effects on indigenous 
microbial diversity and function. Here, we have investigated whether dietary 
supplementation—another method used to modulate gut composition and function—could 
be used to ameliorate the side effects of antibiotics. We perturbed gut bacterial communities 
with gentamicin and ampicillin in anaerobic batch cultures in vitro. Cultures were supplemented 
with either pectin (a non-fermentable fibre), inulin (a commonly used prebiotic that promotes 
the growth of beneficial bacteria) or neither. Although antibiotics often negated the beneficial 
effects of dietary supplementation, in some treatment combinations, notably ampicillin  
and inulin, dietary supplementation ameliorated the effects of antibiotics. There is therefore 
potential for using supplements to lessen the adverse effects of antibiotics. Further 
knowledge of such mechanisms could lead to better therapeutic manipulation of the human 
gut microbiota. 
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1. Introduction 
The human colon contains many hundreds of species of bacteria, which collectively play an important 
role in digestion and health. A growing body of work demonstrates the importance of the gut microbiota 
for digesting long-chain molecules in the diet [1], synthesising key nutrients [2], protecting against 
colonisation by pathogenic bacteria, priming the immune system [3], and stimulating hormonal 
pathways that affect various aspects of host physiology [4]. One key challenge for targeting the gut 
microbiota for improved health is how to manage this complex system, in which benefits derive from 
the actions of an assemblage of many species, rather than a single agent. 
Several methods are available for manipulating the gut microbiota. Antibiotics are widely used to 
control pathogenic bacteria. However, antibiotics can have an adverse effect on gut communities by 
reducing the abundance and diversity of commensal microbes [5,6]. There is therefore a need to identify 
ways to reduce the adverse impacts of antibiotics on gut communities. Increased knowledge about ecological 
responses, and how those may affect key metabolic functions, would help design such approaches. 
Another way to manipulate the microbiota is to modify resource supply, either via a controlled diet 
or the addition of dietary supplements. One such approach that promotes the growth of bacteria beneficial 
to human health is the use of prebiotics [7]. Diet plays a major role in shaping gut communities [8], and 
many beneficial functions of gut bacteria relate to the fermentation of non-digestible macromolecules. 
Non-digestible carbohydrates (fibre), including starch, are the main nutrient source for colonic 
bacteria [9]. Bacteria ferment fibre to produce short chain fatty acids (SCFAs) [10], mainly acetate, 
propionate and butyrate [11]. SCFAs afford multiple benefits for the host, including providing an energy 
source for organs and triggering hormone pathways [12]. SCFAs activate free fatty acid receptor  
2 (FFA2), located on the luminal surface of colonic L-cells [13], which induces secretion of anoretic gut 
hormones such as peptide YY (PYY). PYY is released into the circulation and induces anorexigenic 
signalling, which leads to decreased food intake [11]. Dietary intervention to stimulate SCFA production 
and thereby regulate anoretic gut hormones offers a potential strategy to combat the current obesity 
epidemic [14]. High fibre diets and prebiotics such as inulin are known to stimulate growth of beneficial 
bacteria such as Bifidobacterium, and to reduce appetite and the risk of obesity [15,16]. However, exactly 
how these effects are mediated by changes in the microbial community remains unclear. 
Here, we explore whether dietary supplementation can be used to reduce the adverse effects of 
antibiotic treatment on gut diversity and functioning. If so, this might help to devise refined interventions 
combining antibiotic and prebiotic use. We measured the interactive effects of antibiotics and dietary 
supplements on faecal microbial composition and SCFA production in anaerobic batch cultures.  
We monitored bacterial composition by Illumina-sequencing the V4 region of the 16S rRNA gene.  
We also tracked counts of total bacteria, and Bacteroides and Bifidobacterium, two of the main taxa 
involved in fermenting carbohydrates, over 30 h using fluorescence in situ hybridisation (FISH). 
Bacteroides and Bifidobacterium were chosen to study as they comprise a significant component of the 
gut microbiota, and were expected to differ in their responses to both dietary supplements and antibiotics. 
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SCFA concentrations were determined using gas chromatography (GC) [17]. In order to determine 
potential effects of observed changes in bacterial communities on host physiology, we also used an  
in vitro assay to measure PYY release. 
Ampicillin and gentamicin were used to perturb the bacterial community. Ampicillin targets both 
Gram-negative and Gram-positive bacteria, whereas gentamicin targets mainly Gram-negative species. 
Most Bacteroides spp. (Gram-negative) are resistant to both ampicillin (through production of  
beta-lactamase) [18] and gentamicin (because they do not transport the molecule to the ribosomal target 
site) [19], although levels of resistance vary among isolates. In contrast, Bifidobacterium spp.  
(Gram-positive) are widely susceptible to ampicillin but resistant to gentamicin [20,21]. We 
supplemented cultures using two non-digestible carbohydrates, pectin and inulin. Pectin is a complex 
polysaccharide that forms part of the plant cell wall and is found in many plant-based foods [22]. It is 
well fermented by many bacteria in the gut, especially Bacteroides [9]. We chose pectin as a simple 
treatment to examine the effects of a high fibre versus a low fibre diet. Inulin, also a non-digestible 
carbohydrate, is a widely used prebiotic [23] that is also found naturally in many plants including 
artichoke and asparagus. It stimulates the growth of beneficial bacteria such as bifidobacteria [24]. 
2. Experimental Section 
2.1. Faecal Sample Preparation 
Faecal samples used in this study came from healthy human volunteers with no history of 
gastrointestinal illness, who were not regular consumers of pre or probiotics and had not consumed 
antibiotics within the previous 4 months. One volunteer was used per experiment (3 volunteers  
used overall). Faecal samples were donated on the morning of the experiment, and kept under anaerobic 
conditions for use within 30 min. 15–20 g faeces were diluted 1:10 with pre-reduced phosphate buffered 
saline (PBS). The solution was homogenised in a Stomacher 400 circulator (Seward) for 2 min.  
The resulting faecal slurry was used to start batch cultures. 
2.2. Batch Culture Fermentation 
Batch culture fermentation vessels contained 135 mL sterile basal medium (per litre: 2 g  
peptone water, 2 g yeast extract, 0.1 g NaCl, 0.04 g K2HPO4, 0.04 g KH2PO4, 0.01 g MgSO4·7H2O,  
0.01 g CaCl2·6H2O, 2 g NaHCO3, 2 mL Tween 80, 0.05 g hemin, 10 μL vitamin K, 0.5 g  
L-Cysteine HCl, 0.5 g bile salts and 4 mL resazurin solution). A nitrogen gas supply was connected to 
the vessels to sustain an anaerobic environment, and vessels were left to gas overnight. pH was 
maintained at 6.8 via pH electrodes between pH 6.7–6.9 (the distal large intestine has a neutral pH), and 
temperature maintained at 37 °C via a circulating water bath. The following day, each vessel was 
inoculated with 15 mL faecal slurry (1% final concentration). Ampicillin and gentamicin (25 mg) were 
added to appropriate vessels, at concentrations representative of the amount that would typically make 
it to the large intestine. The effect of fermentable fibre was investigated via the addition of pectin  
(1.5 g), which emulated a high fibre diet (The control medium represented a low fibre diet). Effects of 
prebiotic supplementation were examined via the addition of inulin (1.5 g). Samples were collected from 
each vessel over a series of time points (0, 5, 10, 24, 30 and 48 h) and prepared for further assays.  
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Bacterial enumeration was carried out using flurorescence in situ hybridization (FISH), as described by 
Costabile et al. [25]. Probes were commercially synthesised and fluorescently labelled using cyanine 3 
(Cy3). Targeted groups of bacteria were total bacteria, Bacteroides, and Bifidobacterium, using probes 
EUBmix [26], Bac303 [27] and Bif164 [28] respectively. 4,6-diamidino-2-phenylindole (DAPI) nucleic 
acid stain was used to visualise all bacteria under an ultra violet (UV) light. The experiment was repeated 
three times, with a different donor each time. 
2.3. DNA Extraction and 16S Sequencing 
Samples of 1.5 mL collected from batch culture fermentation vessels were centrifuged at 13,000 g 
for 10 min, supernatant was removed and the remaining pellet resuspended in 0.5 mL PBS glycerol (for 
freezing at −20 °C). After thawing, samples were centrifuged at 13,000 g for 5 min. The supernatant was 
discarded and the pellet resuspended in 1 mL PBS. Samples were centrifuged once more, and pellets 
were resuspended in 750 μL bead solution and transferred to bead beating tubes (as supplied). DNA 
extraction was then carried out using Power Fecal DNA isolation kit (#12830-50, MO BIO Laboratories) 
according to manufacturer’s instructions. The 16S rRNA V4 variable region was sequenced using the 
515/806 primer set with barcode on the forward primer. PCR ran with 30 cycles using the HotStarTaq 
Plus Master Mix Kit (Qiagen, Valencia, CA, USA): 94 °C for 3 min; 28 cycles of 94 °C for 30 s, 53 °C 
for 40 s and 72 °C for 1 min; and an elongation step at 72 °C for 5 min. Illumina TruSeq DNA libraries 
were prepared using pooled PCR product purified using calibrated Ampure XP beads. PCR and 
sequencing was performed at MR DNA (www.mrdnalab.com, Shallowater, TX, USA) on a MiSeq 
machine following manufacturer’s guidelines. Sequences were processed using a proprietary analysis 
pipeline (MR DNA, Shallowater, TX, USA): Barcodes and chimeras (sequences shorter than 150 bp and 
those with ambiguous base calls) were removed. Operational taxonomic units (OTUs) were defined by 
clustering at 3% divergence (97% similarity) and taxonomically classified using BLASTn against the 
GreenGenes database [29]. Focusing on the top fifteen most frequent genera across all samples, we used 
the frequency (% of sequences belonging to a particular taxon) of each genus (and of all other genera 
combined) as our data for taxonomic composition. We used principal components analysis (PCA) on 
these data to derive major access of variation in genus frequencies, using the prcomp function in R [30]. 
2.4. SCFA Analyses 
Samples of 1.5 mL collected from batch culture fermentation vessels were centrifuged at 13,000 g 
for 10 min. Supernatants were collected, filtered using a 0.22 μm syringe filter (PVDF) and stored at 4 °C. 
A standard stock solution was prepared for each acid (acetic, propionic, iso-butyric, butyric, iso-valeric, 
valeric and caproic acid) at a concentration of 100 mM. A 10 mM master mix was prepared (1 mL of 
each 100 mM standard, 3 mL H2O) with a final volume of 10 mL. This was serially diluted to create 
standard concentrations of 1 mM, 100 μM, 10 μM, 1 μM, 100 nM and 10 nM. An internal standard 
solution was also prepared; 132.8 μL ethyl-butyrate was added to 9.87 mL H2O to create a 100 mM 
ethyl-butyrate solution. The internal standard was created at a final volume of 10 mL: 100 μL 100 mM 
ethyl-butyrate was added to 337 μL formic acid, followed by H2O. Internal standard and sample were 
then added to vials (225 μL of each). All standards and samples were analysed using a GC method. 
Analysis was performed using Nukol Capillary Column (30 m × 0.23 mm × 1.0 μm), (SUPELCO 
Nutrients 2015, 7 4484 
 
 
Analytical, UK). Injector and detector temperatures were both 250 °C, and helium was used as the carrier 
gas at a flow rate of 5.0 mL min−1. Concentrations of SCFAs present within samples were then calculated. 
2.5. PYY Release Assays 
We followed the methods of Frost et al. [31] described in detail in Supplementary Methods 1.  
In brief, colons were taken from 6 C57BL6 mice (in total). Isolated colonic cells were applied to 1% 
Basement Membrane Matrix (BD Matrigel, VWR)- coated 24-well plates. Following washing, cells 
were then incubated with faecal fluids obtained from anaerobic batch cultures for 2 h at 37 °C. Propionate 
was used as a positive control as previous work has shown that it significantly stimulates PYY  
release [32]. Secretion buffer alone was used to estimate basal release of PYY from colonic L-cells. 
Supernatants and lysates were then collected from each well and PYY concentration was measured by 
radioimmunoassay (RIA). 
2.6. Statistical Analyses 
We ran linear mixed effects models of log(concentration) for each SCFA in turn, including diet (as 
short-hand for dietary supplementation), antibiotic, time and their interactions as fixed effects and 
microcosm as a random effect (to take account of pseudo-replication due to repeated measures). 
Inspection of the plots revealed a saturating response in most cases, so we included time2 into the model. 
Inspection of outputs of models showed that time2 was not significant for interaction terms, so we refitted 
a model with diet * antibiotic * time + time2 as our fixed effects. Analysis of variance (ANOVA) 
confirmed that this formulation did not lead to significant reduction in explanatory power for all SCFAs. 
To examine whether there were significant differences in the effects of inulin versus pectin, we refitted 
the model with an alternative factor coded as “control diet” versus “supplemented diet”, i.e., making no 
distinction between supplements. If this alternative model was not significantly worse than the model 
using separate levels for each diet, we simplified and refer to effects of “diet supplementation” without 
referring separately to inulin or pectin. A similar procedure was used to test whether the two antibiotics 
had different effects. 
3. Results 
3.1. Starting Composition 
The taxonomic composition of cultures at the start (T0) was based on >50,000 reads of the 16S V4 region 
per sample and fell within variation observed in the Human Microbiome Project (HMP) (Figure 1A).  
All communities had low/medium Bacteroides (17.9%–24.0%), high Faecalibacterium (12.7%–15.9%) 
and high Ruminococcus (5.4%–12.3%) frequencies relative to variation across HMP samples [33], which 
corresponds to enterotype 3 in Arumugam et al. [34]. Over 10 h, cultures became more similar to 
communities sampled from colon biopsies (blue dots, Figure 1A), indicated by a significant shift along 
the major axis of variation, corresponding mainly to increased frequency of Bacteroides (mean change 
in principal component 1 (PC1) = 0.195, t = 6.22, conservative df = 2, p = 0.025; Figure 1B). This shows 
that the composition of our faecal communities is similar to the composition in the colon, and therefore 
provides support that our artificial system is representative of the gut microbiota. 
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Figure 1. (A) The first two principal components representing variation in frequencies of 
common genera across Human Microbiome Project samples (grey), stool samples from 
Stearns et al. [35] (also grey), colon samples from Stearns et al. [35] (blue), our starting 
cultures (marked by +) and our time 10 experimental samples (orange). Correlations with 
six main genera are shown. (B) An expanded plot focusing on our experimental samples, with 
arrows showing the change in mean values of principal component 1 (PC1) and principal 
component 2 (PC2) in each experimental treatment. Faecalibacterium (Faec),  
Clostridium (Closr), Roseburia (Rose), Bacteroides (Bac), Parabacteroides (Para). 
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3.2. Changes in Bacterial Abundance 
Supplementation with inulin and pectin led to a significant increase in total bacterial numbers relative 
to control medium (Figure 2A, F2,22 = 3.86, p = 0.037, Table 1). Antibiotic treatment decreased  
cell numbers. The impact of gentamicin was sustained over 30 h (Figure 2B), whereas ampicillin reduced 
numbers over 10 h, but growth recovered later in the experiment (Figure 2C, interaction between 
antibiotic and quadratic time, F4,75 = 4.58, p = 0.0023, Table 1). There was no significant interaction 
between the effects of fermentable fibre and antibiotics on total cell counts. 
Table 1. Linear mixed effects model of bacterial cell counts over time. The best  
models included time as a quadratic term for total bacteria and Bacteroides, and time as a 
factor for Bifidobacterium. 
Response Variable Explanatory Term 
Sum 
Squares
Mean 
Squares
Degrees of 
Freedom 
F p 
Total bacteria Diet 0.159 0.079 2.22 3.86 0.0365 
 Antibiotic 0.239 0.120 2.22 5.81 0.0094 
 Time 0.087 0.044 2.75 2.12 0.1274 
 Antibiotic:Time 0.377 0.094 4.75 4.58 0.0023 
Bacteroides Diet 0.668 0.334 2.27 6.34 0.0055 
 Antibiotic 1.006 0.503 2.27 9.54 0.0007 
 Time 1.949 0.975 2.81 18.48 <0.0001
 Diet:Antibiotic 0.355 0.089 4.27 1.68 0.1826 
 Diet:Time 1.399 0.350 4.81 6.63 0.0001 
 Antibiotic:Time 0.730 0.183 4.81 3.46 0.0116 
 Diet:Antibiotic:Time 1.954 0.244 8.81 4.63 0.0001 
Bifidobacterium Diet 0.048 0.024 2.27 0.70 0.5043 
 Antibiotic 0.156 0.078 2.27 2.29 0.1202 
 Time 0.291 0.097 3.81 2.85 0.0423 
 Diet:Antibiotic 0.087 0.022 4.27 0.64 0.6381 
 Diet:Time 0.438 0.073 6.81 2.15 0.0565 
 Antibiotic:Time 0.957 0.160 6.81 4.70 0.0004 
 Diet:Antibiotic:Time 1.100 0.092 12.81 2.70 0.0041 
We also measured abundances of two key taxa, Bacteroides and Bifidobacterium spp. using  
taxon-specific FISH markers. Bacteroides displayed a significant interaction between fermentable fibre, 
antibiotics and time (F8,81 = 4.63, p = 0.0001, Table 1). Supplementation with pectin and inulin increased 
growth in the absence of antibiotics (Figure 2D). Supplementation with pectin reduced the adverse 
effects of gentamicin after 10 h, whereas inulin reduced the effects of ampicillin (Figure 2E,F). By 30 h, 
however, both supplements reduced the effects of ampicillin. Only gentamicin and inulin continued to 
have a negative effect on bacterial abundance after 30 h. 
Bifidobacterium spp. also displayed a significant interaction between fermentable fibre, antibiotics 
and time (with time as a factor, F12,81 = 2.70, p = 0.004, Table 1). After 10 h, supplementation with inulin 
led to higher counts in the absence of antibiotics (Figure 2G), but this effect was removed by the addition 
of both antibiotics (Figure 2H,I). After 30 h, supplementation with both pectin and inulin increased 
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counts in the absence of antibiotics, but the effect was negated by gentamicin (both pectin and inulin) 
and ampicillin combined with pectin. By 30 h, however, there was no longer a negative effect of 
ampicillin on cultures supplemented with inulin (Figure 2I). 
 
Figure 2. Changes in the abundance of total bacteria (A) to (C), Bacteroides (D) to (F) and 
Bifidobacterium (G) to (I) as determined by FISH counts during the course of the experiment. 
Columns show results with no antibiotics ((A, D, G), solid lines), gentamicin ((B, E, H), 
dashed lines) and ampicillin ((C, F, I), dotted lines) in turn. Standard error bars are shown. 
Black = control; green = inulin; red = pectin. Total (total bacterial abundance),  
Bacteroides (Bac), Bifidobacterium (Bif). Averages across volunteers are shown. 
3.3. Taxonomic Composition 
We focused on the 10 h time point to measure taxonomic composition in more detail using Illumina 
16S V4 sequencing, as bacteria should be in the exponential phase of growth. Variation in taxonomic 
composition was summarised using the same principal components identified in Section 3.1 and  
Figure 1A. The use of fermentable fibre in the absence of antibiotics led to an increase in scores of both 
PC1 and PC2, (Figure 1B, F2,6 = 5.46, 5.68; p = 0.045, 0.042 in turn). Increased PC1 primarily indicates 
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a higher proportion of Bacteroides whereas increased PC2 indicates a higher proportion of 
Faecalibacterium and changes in several genera (Figure 1A, examined further below). Adding 
antibiotics to the basal medium alone led to communities with higher scores for PC2 (Figure 1B,  
F2,6 = 14.55, p = 0.0051). We looked separately at changes in the most frequent 15 genera plus the 
combined frequency of all remaining taxa, which we call ‘other genera’. The change in PC2 
corresponded especially to increased frequency of Faecalibacterium, Ruminococcus, Alistipes, 
Roseburia, and ‘other genera’, and decreased Parabacteroides and the proteobacteria, Shigella and 
Escherichia (Figure S1, Table S1). The only marginal differences between the two antibiotics were that 
Allisonella increased with gentamicin but decreased with ampicillin, and Roseburia increased further 
with gentamicin than ampicillin. Factoring in variation in total counts (i.e., an increase in frequency could 
still be a decrease in abundance if total counts decline), the only significant changes were declines  
in Bacteroides, Parabacteroides, Shigella and Escherichia in the presence of antibiotics (Table S2). 
When applied in combination, there were significant interactions in the effects of fermentable fibre 
and antibiotic on taxonomic composition along PC2 (F4,15.9 =3.64, p = 0.027). The effect of ampicillin 
was reduced by supplementation with fermentable fibre, whereas that of gentamicin was reduced  
by pectin, but amplified by inulin (Figure 1B). Among component taxa, Faecalibacterium, Alistipes and 
Roseburia all displayed significant interactions between fermentable fibre and antibiotics, and their 
responses were highly correlated across treatments (Figures S1 and S2, Table S3). Several other genera 
also showed responses correlated with these taxa and matched the response in PC2 (Figue S2): 
Antibiotics led to increased frequencies in the absence of fibre, little change with pectin, and either little 
change (ampicillin) or an amplified increase (gentamicin) with inulin. Bacteroides displayed a negative 
relationship with the responses of these taxa: For example, we observed an increase with pectin and a 
decrease with inulin when gentamicin was added (Figures S1 and S2). 
We checked the congruence between frequencies estimated by FISH and by 16S sequencing at 10 h. 
There was a significant positive correlation for Bacteroides (t = 3.79, df = 23.7, p = 0.0009) and 
responses across treatments were congruent (Figure S3), although the interaction term between 
fermentable fibre and antibiotic was significant with FISH but not with Illumina (F4,16 = 3.25, p = 0.040 
and F4,18 = 1.45, p = 0.25 respectively). There was no significant relationship between FISH and Illumina 
frequencies for Bifidobacterium across cultures overall (t = 0.64, df = 23.2, p = 0.53), and estimates were 
far lower for Illumina than FISH. Responses across treatments were incongruent between the two 
measures (Figure S3). Bifidobacterium is known to be underrepresented with standard primers [36,37]. 
For this reason, we attach more weight to the FISH results than 16S results for this genus. 
3.4. Short Chain Fatty Acids 
SCFA production, as measured by GC, varied considerably among vessels and over time, ranging 
from 1.4 to 67.0 mM. Supplementation with fermentable fibre increased acetate production significantly 
over time (F1,73.5 = 8.86, p = 0.004, Figure S4). In the absence of fermentable fibre, gentamicin increased 
acetate production marginally while ampicillin decreased it. Fermentable fibre had no effect on acetate 
production in the presence of gentamicin, but increased acetate production with ampicillin (Figure S4, 
interaction between fermentable fibre and antibiotics, F2,21.3 = 4.05, p = 0.032). The main trends, 
therefore, were that gentamicin removed the effects of fermentable fibre, but supplements restored 
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acetate to control levels in the presence of ampicillin. Propionate displayed similar patterns across 
treatments to acetate production. Butyrate levels also varied similarly, except that the effects of 
fermentable fibre with gentamicin became significantly more negative over time (Figure S4, F2,68 = 4.89, 
p = 0.010). This pattern was also found with isobutyrate, and became even more pronounced with 
valerate, isovalerate (both C5) and caproate (C6). Supplementation with pectin and inulin reduced 
production by 30 h (Figure S4). 
To identify independent component of responses, we ran a principal components analysis, then 
modeled the effects of fermentable fibre and antibiotic on the first 3 components, which together 
described 93.2% of the total variation (Figure 3). PC1 represented overall production of SCFAs, as it 
was positively correlated with all SCFAs (Figure 3). Supplementation with fermentable fibre increased 
PC1 (overall production of SCFAs) with no antibiotic treatment and ampicillin treatment, but decreased 
PC1 over time with gentamicin (antibiotic by diet by time interaction, F2,75.7 = 5.70, p = 0.005). 
Interestingly, PC2 represented a gradient from low to high carbon number: High values indicate higher 
concentrations of longer chain and lower concentrations of shorter chain SCFAs (Figure 3, mid  
right panel). Dietary supplements had little effect on PC2 (gradient from low to high carbon number) 
with no antibiotic treatment, whereas PC2 increased over time with gentamicin on the control diet, but 
decreased in both pectin and inulin treatments (antibiotic by diet by time interaction, F2,75 = 5.81,  
p = 0.0045). This indicates proportionately greater production of shorter chain fatty acids (acetate, 
propionate, butyrate) relative to longer chain fatty acids (valerate, isovalerate and caproate) caused by 
supplements combined with antibiotic treatments. Finally, principal component 3 (PC3) represented 
proportionately greater production of branched chain fatty acids (BCFAs) isobutyrate and isovalerate 
relative to acetate and caproate. Carbohydrate supplementation reduced PC3 (BCFA production) 
irrespective of antibiotic treatment (F2,26.6 = 5.92, p = 0.022), indicating proportionately fewer BCFAs 
in supplemented vessels. 
3.5. Effect of Microbial Abundance and Composition on SCFA Production 
We re-ran models to test whether the densities of total bacteria, Bacteroides or Bifidobacterium from 
FISH counts could explain variation in SCFA production (Table 1). We added each bacterial variable in 
turn into the best models for each SCFA and PC1 to PC3 identified above. Additional variation in PC1 
was weakly predicted by Bacteroides, PC2 by total bacteria, and PC3 by none of the bacterial measures. 
The main pattern therefore is that relatively more SCFAs are produced when there are more bacterial cells. 
Focusing on time 10, we looked for correlations between SCFA production and the frequencies of 
different genera, as represented by taxon PC1 and PC2. First, we refitted just the effects of diet and 
antibiotics at time 10 alone. Henceforth, we refer to the principal components from the analysis of taxon 
frequencies as TAXON.PC1 and TAXON.PC2, and the principal components from the analysis of 
SCFAs as SCFA.PC1, SCFA.PC2, and SCFA.PC3. SCFA.PC1 correlated solely with antibiotics, 
SCFA.PC2 did not vary significantly among treatments, and SCFA.PC3 varied solely with diet. We then 
tested whether taxon composition, represented by TAXON.PC1 and TAXON.PC2 in turn, explained 
additional variation in any of the SCFA.PCs. SCFA.PC2 was significantly greater (i.e., producing , 
longer chain fatty acids) when TAXON.PC1 was greater (signifying a lower proportion of Bacteroides, 
t = −3.10, df = 23.1, p = 0.005). We searched for additional correlations with specific genera for the 
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other two components of SCFA variation. SCFA.PC1 was significantly lower (i.e., lower overall SCFA 
production) with higher frequencies of Escherichia (t = −2.82, 21.3, p = 0.01). No taxa were correlates 
of SCFA.PC3. Note, that these tests involved multiple comparisons, finding a significant correlation 
with one taxon is not unlikely even under the null model of no true associations, but we present the 
correlations in a spirit of hypothesis generation rather than testing. 
 
Figure 3. Changes through time of the first three principal components summarising 
variation in short chain fatty acids (SCFAs) log(concentrations). Black = control;  
green = inulin; pink = pectin. Solid = control antibiotics; dashed=gentamicin;  
dotted = ampicillin. The loadings and % variation for each principal component are shown 
in right-hand panels. Principal component 1 (PC1) represents production of all SCFAs 
except caproate. Principal component 2 (PC2) represents increasing concentration of SCFAs 
of longer chain length. Principal component 3 (PC3) represents proportionately increased 
concentration of BCFAs relative to acetate and caproate. 
3.6. PYY 
We were unable to assess the effects of antibiotics on PYY release. A lactate dehydrogenase (LDH) 
assay indicated that faecal fluid samples that contained antibiotics were cytotoxic to colonic L-cells 
(Figure S5A). Both antibiotics had significant cytotoxic effects, but neither pectin nor inulin 
supplementation led to any cytotoxicity (Figure S5B). Incubation of colonic L-cells with faecal fluid 
samples caused a significant increase in PYY release compared to the secretion buffer control  
(Figure S5B). However, there was no significant difference between cultures supplemented with either 
fibre source and unsupplemented cultures. 
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Linear mixed effect models revealed some significant correlations between taxa and PYY release. 
Bifidobacterium (Illumina frequencies) correlated positively with the release of PYY from colonic  
L-cells (t = 3.36, p = 0.006). Bacteroides (FISH counts) was also found to correlate positively with PYY 
release (t = 3.38, p = 0.008). However, Illumina frequencies for Bacteroides were not significant. Results 
also revealed some metabolic correlations: BCFAs isobutyrate (t = −3.8, p = 0.01) and valerate (t = −2.7, 
p = 0.04) had a significant negative relationship with PYY release. 
4. Discussion 
Antibiotics and fermentable fibres interacted in their effects on the composition and metabolic 
functioning of faecal communities. The effect of each fibre depended on which antibiotic was present 
and vice versa. In some cases, fermentable fibre restored growth and/or metabolic function reduced by 
antibiotic treatments, in other cases antibiotics negated the benefits of fermentable fibre. We discuss 
each response type in turn, before returning to general implications for manipulating gut microbiota for 
improved metabolic function. 
Whole faecal communities were cultured in anaerobic batch cultures. Whilst batch conditions do not 
perfectly mimic the gut environment, they were designed to mimic resource availability and physical 
conditions in the colon. Indeed, our comparison with colon biopsies supported that our system is 
representative of the gut microbiota. Total bacterial growth was minimal in the absence of  
fermentable fibre, supplementation with both fermentable fibres resulted in increased bacterial growth 
as additional resources were present. As expected, Bacteroides spp. increased in abundance when pectin 
was added, and Bifidobacterium spp. increased when inulin was added. Bacteroides spp. also increased 
with inulin supplementation (though not as much as with pectin). Inulin fermentation is not ubiquitous 
within Bacteroides, but some species such as B. thetaiotaomicron can ferment it [38]. 
Total bacterial abundance declined with both antibiotics when fermentable fibre was absent. 
Gentamicin had lasting effects, whereas the abundance of cultures treated with ampicillin recovered  
after 30 h. This might reflect the growth of ampicillin-resistant taxa using resources made available by 
the loss of ampicillin-susceptible taxa; or there may have been in situ evolution of ampicillin-resistance, 
for example by mutation in the penicillin binding protein [39]. Alternatively, this may be due to 
degradation of the antibiotic by 30 h, however this still reflects realistic changes expected following a 
dose of antibiotics in vivo. Intriguingly, the effects of antibiotics on focal taxon abundances did not 
mirror those predicted from the literature. Contrary to the expectation of resistance to both antibiotics, 
Bacteroides declined with gentamicin in cultures supplemented with inulin, and with ampicillin in 
cultures supplemented with pectin (although growth with ampicillin had recovered by 30 h). These 
differences could reflect differential growth of sub-populations of Bacteroides able to break down inulin, 
such as B. thetaiotaomicron [38], although they are not expected to be competitive when bifidobacteria 
are present. Alternatively, the responses could reflect indirect effects from increases or decreases in other 
taxa that either facilitate or inhibit growth of each taxon [40]. For example, an in vivo study of the 
combined effects of ampicillin and gentamicin found reduced abundance of Bacteroides, even though 
most should be resistant to both drugs [41]. Ampicillin led to the expected decline in Bifidobacterium 
abundance with both pectin and inulin, although growth was restored with inulin after 30 h. 
Unexpectedly, however, gentamicin reduced growth with both pectin and inulin. Again, this could reflect 
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indirect effects caused by changes in other taxa that facilitate or compete with Bifidobacterium. 
Alternatively, inulin might enhance growth of beta-lactamase secreting taxa, which could reduce 
concentrations of ampicillin over time with benefits for all taxa. 
Similar effects were observed across multiple genera surveyed by 16S sequencing. In control medium, 
application of either antibiotic led to a shift towards lower values of PC1 and higher values of PC2. 
Notably, this was indicative of increased frequency of Faecalibacterium. An increase in 
Faecalibacterium frequency has been observed in ex vivo faecal communities treated with ampicillin 
previously [42], and as a Gram-positive Firmicute, it is expected to be insensitive to gentamicin. As seen 
with FISH data, the effects of antibiotics were modulated by fermentable fibre: Both supplements 
removed the effects of ampicillin on bacterial abundance, whereas only pectin removed the effects  
of gentamicin. Inulin actually amplified changes caused by gentamicin, associated with even greater 
reduction in Bacteroides and increase in Faecalibacterium frequency. The increase in Faecalibacterium 
can readily be explained by the well-known use of inulin by this genus [43,44], although here the effect 
was only detected when gentamicin was added. We cannot explain this interaction based on our results, 
but it could relate to reduction of Gram-negative bacteria that would otherwise compete with 
Faecalibacterium for inulin. 
Dietary supplements also altered the effects of antibiotics on metabolite production.  
Fibre supplementation increased the production of all three main SCFAs and reduced proportions  
of BCFAs, isobutyrate and isovalerate, which result from fermentation of protein [45]. Pectin and inulin 
are amongst the most highly fermented substrates in the gut and are known to stimulate production of 
unbranched SCFAs [12,17]. The responses to antibiotics mirrored changes in Bacteroides abundance 
across treatments, which indeed was the only taxon found to positively correlate with overall SCFA 
production (Escherichia also displayed a negative correlation with total SCFAs). Supplementation with 
both pectin and inulin also led to decreased concentration of longer chain fatty acids over time when 
either antibiotic was present. This component of variation in SCFA correlated with taxon PC1, which 
also mainly reflects the frequency of Bacteroides. Bacteroides taxa ferment polysaccharides to both 
acetate and propionate [46,47], but are not generally thought of as producing butyrate or longer-chain 
fatty acids. Definitively attributing changes in SCFA production to particular taxa was not possible here, 
due to the large number of taxa with correlated responses and the smaller number of repeated measures 
over time. Our results provide hypotheses for future testing. 
We intended to look at the effects of fermentable fibre and antibiotics on PYY release. However,  
an LDH assay indicated that antibiotic treatment was cytotoxic to colonocytes. Although not  
usually toxic, colon cells were directly incubated with antibiotics in our culture system, which appeared 
to cause necrosis. However, we must remember that this is an in vitro method; the system lacks hormones, 
mucins and other physiological components that exist in the human colon. The remaining sample size 
was too small to reveal strong correlations with dietary supplementation. We found no direct effect of 
dietary supplementation or SCFA concentrations on PYY levels. Bifidobacterium frequency was 
positively correlated with the release of PYY, which matches evidence that rats fed with probiotic strains 
of Bifidobacterium exhibit increased plasma levels of PYY in vivo [48]. We also found that BCFAs 
isobutyrate and valerate had a negative effect on PYY release. Isobutyrate and valerate are typically 
products of fat and protein fermentation [49]. We report the results for completeness but future work 
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with larger sample sizes would be needed to verify them. The next stage may be to repeat the study  
using humans, and conduct a feeding study. 
5. Conclusions 
In conclusion, addition of fermentable carbohydrates greatly affected the response of cultured 
communities to antibiotic treatments. Generally, the positive effects of fermentable fibre on bacterial 
growth and SCFA production were removed when antibiotics were applied. However, certain 
combinations of antibiotic and fermentable fibre were able to restore the bacterial community. Notably, 
inulin reduced the negative effects of ampicillin after 30 h, thus restoring metabolic function and taxonomic 
composition using prebiotics. This treatment combination suggests a potential role for prebiotics in 
restoring function during and after antibiotic treatment, which may have broader clinical impacts. 
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